Image Guided Surgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034

Image Guided Surgery Devices Market Summary

Overview:

• The Image Guided Surgery Devices market is estimated at USD 8.51 billion in 2025 and is projected to reach USD 19.42 billion by 2034. Growth is anchored in the rising preference for minimally invasive procedures, the integration of artificial intelligence, robotics, and augmented reality into surgical navigation, and sustained investment in hybrid operating rooms and advanced intraoperative imaging.
• The global Image Guided Surgery Devices market is growing at a CAGR of 9.6% during the forecast period from 2026 to 2034.
• By product type, the endoscopes segment dominated the Image Guided Surgery Devices market with a 31% share in 2025.
• By application, the neurology segment dominated the Image Guided Surgery Devices market with a 34% share in 2025.
• By end-user, the hospitals segment dominated the Image Guided Surgery Devices market with a 70% share in 2025.
• North America dominated the global Image Guided Surgery Devices market revenue with a 45% share in 2025, representing the highest regional market share globally.

Image guided surgery (IGS) devices are advanced medical systems that use real-time and preoperative imaging, including endoscopy, ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and X-ray fluoroscopy, to help surgeons visualize anatomy, plan approaches, and track instruments during procedures. By fusing imaging data with navigation, tracking, and visualization software, these systems let surgeons operate with greater precision through smaller incisions, which reduces complications, radiation exposure, hospital stay, and recovery time. Hospitals, specialty clinics, and ambulatory settings use IGS devices across neurology, orthopedic, ear, nose, and throat (ENT), and oncology surgery, supported by hybrid operating rooms, mobile intraoperative imaging, and surgical planning software. The market is organized by product type across endoscopes, ultrasound systems, MRI systems, CT systems, X-ray fluoroscopy systems, and others; by application across neurology, orthopedic surgery, ENT surgery, oncology surgery, and other applications; by end-user across hospitals, specialty clinics, and others; and by geography. Driven by the shift to minimally invasive surgery, the growing burden of cancer, neurological, and musculoskeletal disease, and rapid advances in AI-enabled navigation, robotics, and augmented reality, image-guided surgery devices have become core infrastructure of the modern precision operating room.

Image Guided Surgery Devices Market Key Growth Drivers

• The growing preference for minimally invasive surgery is driving demand, as image guidance enables smaller incisions, shorter procedures, and faster patient recovery across neurology, orthopedic, ENT, and oncology surgery.
• The rising global burden of cancer, neurological disorders, and musculoskeletal conditions is expanding the surgical caseload, with the International Agency for Research on Cancer projecting cancer cases to rise from 20 million in 2022 to 35 million by 2050.
• Integration of artificial intelligence, robotics, and augmented reality into navigation platforms, such as Medtronic's Stealth AXiS, Philips' AI-powered DeviceGuide, and Medivis' augmented reality cranial navigation, is improving surgical accuracy and workflow.
• Advances in imaging technology, including higher-resolution endoscopy, 3D reconstruction, mobile intraoperative CT, and AI-enhanced fluoroscopy, are widening the range of procedures that can be performed under image guidance.
• Expansion of hybrid operating rooms and integrated surgical suites is increasing hospital capital investment in multimodality imaging and navigation equipment.
• An ageing population, rising healthcare spending, and supportive reimbursement and regulatory pathways, particularly frequent FDA clearances and CE marking, are accelerating adoption of advanced surgical imaging.
• The convergence of minimally invasive surgery, disease burden, AI and robotics integration, and hybrid operating room investment is expected to sustain strong growth in the market through 2034.

Key Companies in Image Guided Surgery Devices Market

The competitive landscape is led by the following active manufacturers:

• Medtronic
• Koninklijke Philips N.V.
• Siemens Healthcare GmbH
• General Electric
• Perlong Medical Equipment Co., Ltd.
• Brainlab AG
• Olympus Corporation
• Stryker
• Abbott
• Getinge AB

Factors Contributing to the Growth of the Image Guided Surgery Devices Market

Market Drivers

Rising Preference for Minimally Invasive Surgery

The most powerful driver of the Image Guided Surgery Devices market is the global shift from open surgery to minimally invasive procedures. Image guidance lets surgeons see and track instruments relative to patient anatomy in real time through small access points, reducing blood loss, infection risk, hospital stay, and recovery time. Minimally invasive approaches now account for a large and growing share of surgeries in developed healthcare systems, and endoscopic, ultrasound-guided, and fluoroscopy-guided techniques are being extended to more complex neurology, orthopedic, ENT, and oncology cases. Because minimally invasive surgery depends on indirect visualization, every additional procedure moved away from open surgery raises demand for endoscopes, intraoperative imaging, and navigation systems. As patient and payer preference for faster recovery strengthens, adoption of image-guided surgery devices expands directly, anchoring market growth through 2034.

Rising Disease Burden Across Neurology, Orthopedics, and Oncology

The growing burden of cancer, neurological disease, and musculoskeletal disorders is expanding the pool of patients who need precision surgery. The International Agency for Research on Cancer recorded 20 million new cancer cases in 2022 and projects 35 million by 2050, while brain tumors, spinal disorders, trauma, and degenerative joint disease continue to rise with an ageing population. Tumor resection, spinal fusion, joint replacement, sinus surgery, and brain biopsy all depend on accurate localization of anatomy and instruments, and image guidance reduces the risk of damaging critical structures such as nerves, vessels, and eloquent brain tissue. As disease prevalence and the number of eligible patients increase, the volume and complexity of image-guided procedures rise in step, translating into sustained demand for imaging and navigation hardware and software across the forecast period.

Market Restraints

Despite strong momentum, the Image Guided Surgery Devices market faces material constraints. The high capital cost of imaging and navigation systems is a significant barrier, with advanced platforms often costing in the range of USD 1 to 2 million per system, and annual maintenance and service commonly adding a meaningful further percentage of purchase cost, which limits adoption by smaller hospitals, specialty clinics, and providers in emerging economies. A shortage of surgeons, radiographers, and technicians trained to operate complex navigation and intraoperative imaging systems, together with long learning curves, slows utilization and workflow integration. Hybrid operating rooms require costly structural modification, radiation shielding, and integration with existing equipment, which lengthens deployment timelines. Stringent and evolving regulatory requirements across the FDA, the European Union Medical Device Regulation, and other regimes extend development timelines and raise compliance costs, while software-related recalls and accuracy concerns heighten scrutiny of navigation systems. Registration inaccuracy, line-of-sight limitations, and image-to-patient mismatch can reduce clinical confidence, and radiation exposure from X-ray fluoroscopy and CT-based guidance remains a safety consideration for patients and staff. Reimbursement for newer navigation and robotics-enabled procedures remains uneven across geographies, and tariffs and supply-chain disruptions in imaging components and semiconductors can raise costs. Together, these cost, workforce, regulatory, and integration barriers temper the pace of growth, even as the underlying drivers of minimally invasive surgery, disease burden, and technology convergence remain firmly intact.

Image Guided Surgery Devices Market Segment Analysis

The Image Guided Surgery Devices Market is segmented by product type (endoscopes, ultrasound systems, magnetic resonance imaging (MRI) systems, computed tomography (CT) systems, X-ray fluoroscopy systems, and others), application (neurology, orthopedic surgery, ear, nose, and throat (ENT) surgery, oncology surgery, and other applications), end-user (hospitals, specialty clinics, and others), and geography (North America, Europe, Asia-Pacific, and Rest of World).

By Product Type

Dominant Subsegment: Endoscopes.

The endoscopes segment accounted for 31% of the Image Guided Surgery Devices Market in 2025. Endoscopes are the leading product type because they are the most widely deployed visualization tool in minimally invasive surgery, used across ENT, neurology, orthopedic, and oncology procedures as well as general, urologic, and gastrointestinal surgery. Their relatively lower cost per unit compared with CT and MRI systems, combined with high procedure volumes, frequent replacement cycles, and recurring demand for scopes, camera heads, light sources, and processors, sustains large and dependable revenue. Continuous innovation, including 4K and 3D imaging, fluorescence-guided visualization, and AI-assisted image enhancement, as exemplified by Olympus' VISERA ELITE III platform, is widening clinical use and encouraging upgrades. Endoscopes are also increasingly combined with navigation, which lets surgeons track instruments in sinus and skull-base surgery. While ultrasound systems are expected to grow rapidly on the back of portability and lower cost, and CT, MRI, and X-ray fluoroscopy systems anchor hybrid operating rooms, the breadth, frequency, and recurring nature of endoscopy keep endoscopes the dominant product type across the forecast period.

By Application

Dominant Subsegment: Neurology.

The neurology segment accounted for 34% of the Image Guided Surgery Devices Market in 2025. Neurology, which includes cranial and spinal neurosurgery, is the leading application because brain and spine procedures were among the first to adopt image guidance and depend on it most heavily. The need to protect eloquent brain tissue, nerves, and vessels makes millimeter-scale accuracy essential, and neuronavigation, intraoperative MRI and CT, and ultrasound are standard in tumor resection, biopsy, shunt placement, deep brain stimulation, and spinal fusion. Manufacturers continue to invest in this space: Medtronic's Stealth AXiS combines navigation, planning, and robotics for spine surgery, Stryker commercially launched Q Guidance with cranial guidance software in 2023, Brainlab's navigation and mobile imaging are widely used in neurosurgery, and Medivis received clearance in December 2025 for augmented reality cranial navigation. A rising burden of brain tumors, trauma, and spinal disorders sustains caseload. While oncology surgery is expected to grow quickly as tumor margin visualization improves, and orthopedic and ENT surgery provide steady demand, the depth of neuronavigation adoption keeps neurology the dominant application across the forecast period.

Image Guided Surgery Devices Market Region Analysis

Dominant Region: North America

North America accounted for 45% of the global Image Guided Surgery Devices Market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects advanced healthcare infrastructure, high adoption of cutting-edge surgical technologies, the strong presence of leading device manufacturers, and favorable reimbursement and regulatory pathways, particularly in the United States. North America hosts a large concentration of hybrid operating rooms, academic medical centers, and early adopters of AI-enabled navigation and robotic-assisted surgery, and frequent FDA clearances, including recent clearances for Medtronic, Philips, GE HealthCare, Siemens Healthineers, and Abbott platforms, accelerate commercialization. High healthcare spending, a high burden of cardiovascular, neurological, musculoskeletal, and oncologic disease, and strong research and development investment anchor the region's continued leadership across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Image Guided Surgery Devices market. The region's elevated CAGR is driven by rising healthcare investment, expanding hospital infrastructure, a growing burden of cancer, cardiovascular, and neurological disease, and rapid adoption of advanced surgical technologies across China, Japan, India, South Korea, and Australia. China is investing in AI-enabled navigation, robotic-assisted surgery, and smart hospital infrastructure, Japan hosts leading endoscope and imaging manufacturers and an advanced surgical market, and India and Southeast Asia are expanding private hospital networks and medical tourism. Government healthcare reforms, improving access to care, rapid urbanization, and growing awareness of minimally invasive techniques are accelerating adoption, while domestic manufacturers such as Perlong Medical expand lower-cost endoscope, ultrasound, and X-ray offerings. The combination of rising disease burden, infrastructure build-out, and increasing affordability positions Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 45% of the global Image Guided Surgery Devices Market revenue in 2025. The United States dominates on the strength of its advanced hospital infrastructure, early adoption of AI, robotics, and hybrid operating rooms, favorable reimbursement, and the headquarters and clinical networks of leading device manufacturers, while frequent FDA clearances and strong research and development investment reinforce its leadership.

Europe

Europe is a large and advanced regional market, supported by strong public and private healthcare systems, a rising ageing population, and growing adoption of minimally invasive surgery, hybrid operating rooms, and AI-enabled imaging. Europe is also the home base of leading manufacturers such as Philips, Siemens Healthineers, Brainlab, and Getinge, and collaboration between hospitals and medical technology firms accelerates technology adoption, for example, flagship Brainlab spine and trauma navigation suites at leading orthopedic hospitals across Germany, France, the United Kingdom, Italy, and Spain.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by rising healthcare investment, expanding hospital infrastructure, and a growing patient population with neurological, cardiovascular, and oncologic disease across China, Japan, India, South Korea, and Australia. China's adoption of AI-powered navigation and robotic-assisted surgery, Japan's strength in endoscopy and imaging, and growing medical tourism and awareness of advanced surgical techniques across emerging economies are accelerating regional adoption.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital and surgical infrastructure, rising investment in advanced healthcare in the Gulf states, growing demand for minimally invasive surgery and diagnostic imaging, and training and equipment donation programs are gradually broadening access, although high equipment costs, limited healthcare budgets, and skills shortages continue to constrain adoption.

Image Guided Surgery Devices Market Competitive Landscape

The Image Guided Surgery Devices Market is classified as Moderately Concentrated. A group of global imaging and medical technology leaders with broad portfolios and large installed bases, including Medtronic, Koninklijke Philips N.V., Siemens Healthcare GmbH, General Electric, and Olympus Corporation, anchors the top tier, while specialized navigation, orthopedic, and hospital-integration players such as Brainlab AG, Stryker, Getinge AB, and Abbott compete through software, mobile intraoperative imaging, and integrated surgical ecosystems, and cost-focused manufacturers such as Perlong Medical Equipment Co., Ltd. extend access in price-sensitive markets, increasing competition in the fastest-growing product and application segments.

The competitive landscape can be evaluated across the following dimensions:

• Market concentration: Moderately concentrated, with global imaging and medical technology leaders anchoring the top tier and a growing field of specialized navigation, AI, and augmented reality providers.
• Leading players: Medtronic, Koninklijke Philips N.V., Siemens Healthcare GmbH, General Electric, and Olympus Corporation anchor the top tier through broad imaging portfolios and large installed bases.
• Geographic reach: Leaders operate global sales, service, and clinical-training networks across North America, Europe, and Asia-Pacific; Perlong Medical exports to a wide range of emerging markets.
• Product portfolio strength: Top players offer integrated portfolios spanning endoscopes, ultrasound, MRI, CT, X-ray fluoroscopy, navigation systems, planning software, and hybrid operating room equipment.
• Technology and software leadership: AI-driven image processing, navigation software, and workflow integration, such as Siemens Healthineers' Optiq AI and Philips' EchoNavigator, are a decisive advantage.
• Strategic partnerships: Collaborations with implant makers, software specialists, and clinical centers, such as Philips with Edwards Lifesciences, Brainlab with Precision NeuroMed, and Getinge with GE HealthCare, extend reach.
• Regulatory track record: Frequent FDA 510(k) clearances and CE marking, including Medtronic's Stealth AXiS, GE HealthCare's Allia Moveo, and Abbott's Ultreon 3.0, are key competitive moats.
• Manufacturing capabilities: Scale in optics, detectors, magnets, and precision tracking hardware, together with global service networks, underpin competitive positioning.
• Innovation focus: AI-enabled navigation, robotic-assisted surgery, augmented and mixed reality, mobile intraoperative imaging, and hybrid operating room integration.

Image Guided Surgery Devices Market Recent Developmental Activities

In May 2026, Siemens Healthcare GmbH, received FDA clearance for six new Artis interventional imaging systems featuring its Optiq AI imaging chain, including the Artis vision, icono.explore, and genio platforms. Strategic significance: Strengthens AI-enhanced fluoroscopy and angiography offerings for image-guided procedures and hybrid operating rooms.

In April 2026, Abbott received FDA clearance and CE Mark for its Ultreon 3.0 AI-powered coronary imaging platform based on optical coherence tomography. Strategic significance: Extends Abbott's AI-enabled intravascular imaging portfolio for precision-guided intervention.

Image Guided Surgery Devices Market Segmentation

Image Guided Surgery Devices Market by Product Type

• Endoscopes
• Ultrasound Systems
• Magnetic Resonance Imaging (MRI) Systems
• Computed Tomography (CT) Systems
• X-Ray Fluoroscopy Systems
• Others

Image Guided Surgery Devices Market by Application

• Neurology
• Orthopedic Surgery
• Ear, Nose, and Throat (ENT) Surgery
• Oncology Surgery
• Other Application

Image Guided Surgery Devices Market by End-User

• Hospitals
• Specialty Clinics
• Others

Image Guided Surgery Devices Market by Geography

• North America Image Guided Surgery Devices Market
• United States Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Canada Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Mexico Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Europe Image Guided Surgery Devices Market
• Germany Image Guided Surgery Devices Market Size in USD million (2023-2034)
• United Kingdom Image Guided Surgery Devices Market Size in USD million (2023-2034)
• France Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Italy Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Spain Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Rest of Europe Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Asia-Pacific Image Guided Surgery Devices Market
• China Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Japan Image Guided Surgery Devices Market Size in USD million (2023-2034)
• India Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Australia Image Guided Surgery Devices Market Size in USD million (2023-2034)
• South Korea Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Rest of Asia-Pacific Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Rest of the World (RoW) Image Guided Surgery Devices Market
• Middle East Image Guided Surgery Devices Market Size in USD million (2023-2034)
• Africa Image Guided Surgery Devices Market Size in USD million (2023-2034)
• South America Image Guided Surgery Devices Market Size in USD million (2023-2034)

Key Takeaways from the Image Guided Surgery Devices Market Report Study

• Market size analysis for the current Image Guided Surgery Devices market size (2025), and market forecast for 9 years (2026 to 2034).
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
• Key companies dominating the global Image Guided Surgery Devices market.
• Various opportunities available for competitors in the Image Guided Surgery Devices market space.
• What are the top-performing segments in 2025? How will these segments perform in 2034?
• Which are the top-performing regions and countries in the current Image Guided Surgery Devices market scenario?
• Which are the regions and countries where companies should concentrate their opportunities for Image Guided Surgery Devices market growth in the future?

Target audience who can benefit from this Image Guided Surgery Devices market report study

• Image Guided Surgery Devices product providers
• Research organizations and consulting companies
• Image Guided Surgery Devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in Image Guided Surgery Devices
• Various end-users who want to know more about the Image Guided Surgery Devices market and the latest technological developments in the Image Guided Surgery Devices market.

Frequently Asked Questions:

Q1. What is the growth rate of the Image Guided Surgery Devices market?

The Image Guided Surgery Devices market is projected to expand at a CAGR of 9.6% during the forecast period from 2026 to 2034.

Q2. What is the market size of the Image Guided Surgery Devices market?

The Image Guided Surgery Devices market is estimated at USD 8.51 billion in 2025 and is projected to reach USD 19.42 billion by 2034.

Q3. Which region dominates the Image Guided Surgery Devices market?

North America dominated the Image Guided Surgery Devices Market with a 45% share of global revenue in 2025, supported by advanced healthcare infrastructure, high adoption of AI-enabled and robotic surgical technologies, the strong presence of leading manufacturers, and favorable reimbursement and FDA regulatory pathways. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the Image Guided Surgery Devices market?

The principal drivers are the rising preference for minimally invasive surgery; the growing burden of cancer, neurological, and musculoskeletal disease, with the International Agency for Research on Cancer projecting cancer cases to rise from 20 million in 2022 to 35 million by 2050; the integration of artificial intelligence, robotics, and augmented reality into navigation platforms; advances in surgical imaging and the expansion of hybrid operating rooms; and a supportive regulatory and investment environment.

Q5. Who are the major players in the Image Guided Surgery Devices market?

The major players include Medtronic, Koninklijke Philips N.V., Siemens Healthcare GmbH, General Electric, Perlong Medical Equipment Co., Ltd., Brainlab AG, Olympus Corporation, Stryker, Abbott, and Getinge AB, among other active providers profiled in the Competitive Landscape section. Medtronic, Philips, Siemens Healthineers, GE HealthCare, and Olympus lead through broad imaging portfolios and large installed bases.